Arcutis Biotherapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Westlake Village, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Arcutis Biotherapeutics, Inc. has filed 851 SEC EDGAR filings since 09 Sep 2019

SEC filing history

Showing 651-675 of 851 matching filings.

Per page
25
Current page
27
4

FORM 4

Filing date
11 Jun 2021
Reporting date
09 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Jun 2021
Reporting date
09 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Jun 2021
Reporting date
09 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Jun 2021
Reporting date
09 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Jun 2021
Reporting date
09 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
09 Jun 2021
Reporting date
07 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Jun 2021
Reporting date
01 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Jun 2021
Reporting date
01 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
25 May 2021
Reporting date
21 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A

Filing date
19 May 2021
Reporting date
20 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A

Filing date
12 May 2021
Reporting date
20 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 May 2021
Reporting date
10 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91349

AMENDMENT NO. 3 TO SCHEDULE 13D

Filing date
12 May 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 May 2021
Reporting date
07 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 May 2021
Reporting date
05 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-252612

424B5

Filing date
06 May 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 May 2021
Reporting date
03 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 May 2021
Reporting date
30 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
04 May 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-39186

DEFA 14A

Filing date
27 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-39186

DEF 14A

Filing date
27 Apr 2021
Reporting date
09 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
23 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
22 Apr 2021
Reporting date
20 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .